1. Pink Sheet
  2. >>Market Access

Lilly Gains Amyvid Approval, But Reimbursement Still A Hurdle

 
• By Lisa LaMotta

Lilly’s Avid has gained approval for its imaging agent Amyvid, a new tool in the Alzheimer’s disease diagnosis arsenal.

After a negative advisory committee vote and FDA rejection, Eli Lilly & Co. received approval for its imaging agent Amyvid (florbetapir) on April 6. Amyvid could change the way doctors diagnose Alzheimer’s disease, but obstacles still remain for the agent.

Amyvid, a radioactive diagnostic agent, shows the amount of beta-amyloid plaque present in the brain during a positron emission tomography (PET) scan. Autopsies of patients with Alzheimer’s disease have shown significant amounts of the amyloid plaque present in the brain

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from Pink Sheet

Inclusive By Design: UK Pilots Diversity Plans For Drug & Device Trials

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada

 
• By Eliza Slawther

Companies that use the European Medicines Agency as a reference regulator for the UK’s International Recognition Procedure can expect a faster approval than those that use other national regulators, such as those in the US and Canada, an MHRA spokesperson has said.

FDA Use Of Artificial Intelligence Will Help US Retain Biotech Leadership

 
• By Sue Sutter and Derrick Gingery

At a House subcommittee hearing, HHS Secretary Robert F. Kennedy Jr. rebutted lawmaker concerns that NIH cuts will drive research and scientists to other countries and said he does not want to advise parents on vaccinating children for measles, chickenpox or polio.